Archive: 27/07/2017
Seattle Children's opens CD22 CAR T-cell immunotherapy trial for children and young adults
After seeing promising results in phase 1 of the Pediatric Leukemia Adoptive Therapy (PLAT-02) trial with 93 percent of patients with relapsed or refractory acute lymphoblastic leukemia (ALL) achieving complete initial remission, ...
Jul 27, 2017